A citation-based method for searching scientific literature

Peiwei Chai, Ruobing Jia, Yongyun Li, Chuandi Zhou, Xiang Gu, Ludi Yang, Hanhan Shi, Hao Tian, Huimin Lin, Jie Yu, Ai Zhuang, Shengfang Ge, Renbing Jia, Xianqun Fan. Prog Retin Eye Res 2022
Times Cited: 6







List of co-cited articles
20 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Molecular Changes in Retinoblastoma beyond RB1: Findings from Next-Generation Sequencing.
Jasmine H Francis, Allison L Richards, Diana L Mandelker, Michael F Berger, Michael F Walsh, Ira J Dunkel, Mark T A Donoghue, David H Abramson. Cancers (Basel) 2021
18
33

Retinoblastoma for Pediatric Ophthalmologists.
Alaa AlAli, Stephanie Kletke, Brenda Gallie, Wai-Ching Lam. Asia Pac J Ophthalmol (Phila) 2018
26
33

MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers.
Khodayar Golabchi, Rahim Soleimani-Jelodar, Nazila Aghadoost, Fatemeh Momeni, Abdullah Moridikia, Javid Sadri Nahand, Aria Masoudifar, Hasan Razmjoo, Hamed Mirzaei. J Cell Physiol 2018
92
33

Circ_0075804 promotes the malignant behaviors of retinoblastoma cells by binding to miR-138-5p to induce PEG10 expression.
Yanling Zhang, Xiaoyan Dou, Qinghui Kong, Yuying Li, Xing Zhou. Int Ophthalmol 2022
3
66

The genomic landscape of retinoblastoma: a review.
Brigitte L Thériault, Helen Dimaras, Brenda L Gallie, Timothy W Corson. Clin Exp Ophthalmol 2014
116
33

Circular RNA circ-FAM158A promotes retinoblastoma progression by regulating miR-138-5p/SLC7A5 axis.
Tongmei Zheng, Weifang Chen, Xiuchun Wang, Weiguo Cai, Fujin Wu, Chaobin Lin. Exp Eye Res 2021
7
33

Long non-coding RNA H19 suppresses retinoblastoma progression via counteracting miR-17-92 cluster.
Aihui Zhang, Weiwei Shang, Qiaoli Nie, Ting Li, Suhui Li. J Cell Biochem 2018
44
33

Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
Fariba Ghassemi, Carol L Shields, Hadi Ghadimi, Alireza Khodabandeh, Ramak Roohipoor. JAMA Ophthalmol 2014
78
33

Mutation and cancer: statistical study of retinoblastoma.
A G Knudson. Proc Natl Acad Sci U S A 1971
33

Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.
Diane E Rushlow, Berber M Mol, Jennifer Y Kennett, Stephanie Yee, Sanja Pajovic, Brigitte L Thériault, Nadia L Prigoda-Lee, Clarellen Spencer, Helen Dimaras, Timothy W Corson,[...]. Lancet Oncol 2013
199
33

Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
Armin R Afshar, Melike Pekmezci, Michele M Bloomer, Nicola J Cadenas, Meredith Stevers, Anuradha Banerjee, Ritu Roy, Adam B Olshen, Jessica Van Ziffle, Courtney Onodera,[...]. Ophthalmology 2020
26
33

Non-canonical functions of the RB protein in cancer.
Frederick A Dick, David W Goodrich, Julien Sage, Nicholas J Dyson. Nat Rev Cancer 2018
88
33

Molecular alterations in retinoblastoma beyond RB1.
Vanessa Mendonça, Anna Claudia Evangelista, Bruna P Matta, Miguel Ângelo M Moreira, Paulo Faria, Evandro Lucena, Héctor N Seuánez. Exp Eye Res 2021
3
66

Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications.
Francis L Munier, Marie-Claire Gaillard, Aubin Balmer, Sameh Soliman, Gregory Podilsky, Alexandre P Moulin, Maja Beck-Popovic. Br J Ophthalmol 2012
223
33

Retinoblastoma.
Helen Dimaras, Timothy W Corson, David Cobrinik, Abby White, Junyang Zhao, Francis L Munier, David H Abramson, Carol L Shields, Guillermo L Chantada, Festus Njuguna,[...]. Nat Rev Dis Primers 2015
267
33

Inactivation of the p53 pathway in retinoblastoma.
Nikia A Laurie, Stacy L Donovan, Chie-Schin Shih, Jiakun Zhang, Nicholas Mills, Christine Fuller, Amina Teunisse, Suzanne Lam, Yolande Ramos, Adithi Mohan,[...]. Nature 2006
444
33

Advances and Challenges of HDAC Inhibitors in Cancer Therapeutics.
Jesse J McClure, Xiaoyang Li, C James Chou. Adv Cancer Res 2018
151
33

The Role of Histone Deacetylase Inhibitors in Uveal Melanoma: Current Evidence.
Marilita M Moschos, Maria Dettoraki, Sofia Androudi, Dimitrios Kalogeropoulos, Anastasios Lavaris, Nikolaos Garmpis, Christos Damaskos, Anna Garmpi, Michael Tsatsos. Anticancer Res 2018
29
33

Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy.
C L Shields, E M Fulco, J D Arias, C Alarcon, M Pellegrini, P Rishi, S Kaliki, C G Bianciotto, J A Shields. Eye (Lond) 2013
117
33

Tumor suppressor and oncogenic role of long non-coding RNAs in cancer.
Esra Guzel, Tugba Muhlise Okyay, Burhanettin Yalcinkaya, Seymanur Karacaoglu, Melek Gocmen, Muhammed Huseyin Akcakuyu. North Clin Istanb 2019
37
16


Aqueous Humor Is Superior to Blood as a Liquid Biopsy for Retinoblastoma.
Jesse L Berry, Liya Xu, Ashley Polski, Rima Jubran, Peter Kuhn, Jonathan W Kim, James Hicks. Ophthalmology 2020
17
16

Expression profiles and prognostic value of miRNAs in retinoblastoma.
Lara Elis Alberici Delsin, Karina Bezerra Salomao, Julia Alejandra Pezuk, Maria Sol Brassesco. J Cancer Res Clin Oncol 2019
22
16

Reduction of circular RNA expression associated with human retinoblastoma.
Jiao Lyu, Yu Wang, Qiupeng Zheng, Peiyan Hua, Xiuyu Zhu, Jiakai Li, Jing Li, Xunda Ji, Peiquan Zhao. Exp Eye Res 2019
20
16





Aqueous Humor Markers in Retinoblastoma, a Review.
Benjamin K Ghiam, Liya Xu, Jesse L Berry. Transl Vis Sci Technol 2019
15
16

Identification and Insilico Analysis of Retinoblastoma Serum microRNA Profile and Gene Targets Towards Prediction of Novel Serum Biomarkers.
Madhu Beta, Nalini Venkatesan, Madavan Vasudevan, Umashankar Vetrivel, Vikas Khetan, Subramanian Krishnakumar. Bioinform Biol Insights 2013
46
16

Circular RNAs: Novel Promising Biomarkers in Ocular Diseases.
Nan Guo, Xiu-Fen Liu, Om Prakash Pant, Dan-Dan Zhou, Ji-Long Hao, Cheng-Wei Lu. Int J Med Sci 2019
37
16


Non-invasive diagnosis of retinoblastoma using cell-free DNA from aqueous humour.
Amy Gerrish, Edward Stone, Samuel Clokie, John R Ainsworth, Helen Jenkinson, Maureen McCalla, Carol Hitchcott, Isabel Colmenero, Stephanie Allen, Manoj Parulekar,[...]. Br J Ophthalmol 2019
33
16

Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types.
Julia Salzman, Charles Gawad, Peter Lincoln Wang, Norman Lacayo, Patrick O Brown. PLoS One 2012
16

A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3.
Xiaoyu He, Peiwei Chai, Fang Li, Leilei Zhang, Chuandi Zhou, Xiaoling Yuan, Yongyun Li, Jie Yang, Yingxiu Luo, Shengfang Ge,[...]. Mol Cancer 2020
32
16

Circulating tumor DNA as a liquid biopsy for cancer.
Ellen Heitzer, Peter Ulz, Jochen B Geigl. Clin Chem 2015
487
16




Long non-coding RNAs in ocular diseases: new and potential therapeutic targets.
Lixia Zhang, Yanhan Dong, Yujie Wang, Jinning Gao, Jiayi Lv, Jingguo Sun, Mengjie Li, Meng Wang, Zhihong Zhao, Jianxun Wang,[...]. FEBS J 2019
27
16




Establishing the Clinical Utility of ctDNA Analysis for Diagnosis, Prognosis, and Treatment Monitoring of Retinoblastoma: The Aqueous Humor Liquid Biopsy.
Liya Xu, Mary E Kim, Ashley Polski, Rishvanth K Prabakar, Lishuang Shen, Chen-Ching Peng, Mark W Reid, Patricia Chévez-Barrios, Jonathan W Kim, Rachana Shah,[...]. Cancers (Basel) 2021
15
16


Outcome of retinoblastoma in east Africa.
R J C Bowman, M Mafwiri, P Luthert, J Luande, M Wood. Pediatr Blood Cancer 2008
76
16


LncRNA HOTAIR/miR-613/c-met axis modulated epithelial-mesenchymal transition of retinoblastoma cells.
Ge Yang, Yang Fu, Xiaoyan Lu, Menghua Wang, Hongtao Dong, Qiuming Li. J Cell Mol Med 2018
40
16

A novel in vitro three-dimensional retinoblastoma model for evaluating chemotherapeutic drugs.
Moutushy Mitra, Chandana Mohanty, Anju Harilal, Uma K Maheswari, Sanjeeb Kumar Sahoo, Subramanian Krishnakumar. Mol Vis 2012
25
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.